DIRECTOR AGREEMENTDirector Agreement • March 29th, 2016 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 29th, 2016 Company Industry JurisdictionThis DIRECTOR AGREEMENT is made as of March 17, 2016 (the “Agreement”), by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Anthony Fiorino, M.D., Ph.D., an individual with an address 308 Churchill Road, Teaneck, NJ, 07666 (the “Director”).